Zhanping Wu
@Vivo Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$1.208BTotal holdings43
Assets growth rate11.63%Assets growth rate (2-Q avg)-1.65%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Vivo Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 43 positions.
Assets under management
The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.208B in assets, with a quarterly growth rate of 11.63% and a 2-quarter average growth rate of -1.65%. The portfolio is managed by Zhanping Wu, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
AVDLAvadel Pharmaceuticals Plc
| 0% | $55.848M 3.972M shares@ $14.07 avg price | Exited |
TARSTarsus Pharmaceuticals Inc
| 0% | $15.372M 565,550 shares@ $27.18 avg price | Exited |
ZLABZai Lab Ltd
| 0% | $9.206M 531,198 shares@ $17.33 avg price | Exited |
ALGSAligos Therapeutics Inc
| 0% | $1.241M 3.547M shares@ $0.36 avg price | Exited |
AADIAadi Bioscience Inc
| 0% | $743,975 509,572 shares@ $1.46 avg price | Exited |